{
    "Trade/Device Name(s)": [
        "N Latex FLC kappa",
        "N Latex FLC lambda"
    ],
    "Submitter Information": "Siemens Healthcare Diagnostics Products GmbH",
    "510(k) Number": "K201496",
    "Predicate Device Reference 510(k) Number(s)": [
        "K031016"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DFH",
        "DEH"
    ],
    "Summary Letter Date": "October 29, 2021",
    "Summary Letter Received Date": "August 2, 2021",
    "Submission Date": "July 29, 2021",
    "Regulation Number(s)": [
        "21 CFR 866.5550"
    ],
    "Regulation Name(s)": [
        "Immunoglobulin (Light Chain Specific) Immunological Test System"
    ],
    "Analyte Class(es)": [
        "immunology"
    ],
    "Analyte(s)": [
        "Free kappa light chains",
        "Free lambda light chains"
    ],
    "Specimen Type(s)": [
        "Serum",
        "EDTA plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "BN Systems",
        "Atellica CH Analyzer",
        "BN II",
        "BN ProSpec Systems"
    ],
    "Method(s)/Technology(ies)": [
        "Particle-enhanced immunonephelometry"
    ],
    "Methodologies": [
        "Immunonephelometric determination"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for Siemens N Latex FLC kappa and lambda particle-enhanced immunonephelometric assays for free light chains in serum and EDTA plasma to aid in diagnosis and monitoring of multiple myeloma, immunoglobulin light-chain amyloidosis, and MGUS.",
    "Indications for Use Summary": "Aids in the quantitative determination of free light chains (kappa or lambda) in human serum and EDTA plasma, supporting the diagnosis and monitoring of multiple myeloma and immunoglobulin light-chain amyloidosis, and evaluation of MGUS, on BN Systems and Atellica CH Analyzer.",
    "fda_folder": "Immunology"
}